From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

MGC Pharmaceuticals shares collapse as consolidation kicks in, I'm 99.3% ahead on this short call - more to come!

By Tom Winnifrith | Thursday 2 November 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I first published a red flag dossier on MGC Pharmaceuticals (MXC) when the shares were 2.25p on 11 January 2022. The last time I wrote they were 0.055p on September 26 2023 as the company announced a bailout placing and 1000 for 1 share consolidation. That consolidation kicked in today and, ceteris paribus the shares should have been 55p. But instead, having risen since September, they have collapsed by 75% to just 15p.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Time left: 10:20:45